
Idiopathic thrombocytopenic purpura (ITP) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051121

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines details of PBS-subsidised eltrombopag and
romiplostim for patients with severe chronic immune idiopathic
thrombocytopenic purpura (ITP).

ITP and listing dates

ITP is a condition with isolated low platelet counts and an increased
tendency for patients to bleed.

Listing dates:

-   romiplostim - 1 April 2011
-   eltrombopag - 1 November 2011

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
item and restriction codes, the PBS schedule and Services Australia
websites.

Related links

Contacting a Health Service Delivery Division Programme Support Officer
(PSO)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA)

Process telephone authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Written Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
